Shorts

Advancing Innovation in Community Oncology Through Collaborative Care

Innovation in Focus: What’s Ahead at COA 2026

Saro's Scripts: Donanemab

What to Expect at COA 2026: Key Trends in Community Oncology

Saro's Scripts: SGLT2 Inhibitors

Expanding Access to Innovative Cancer Therapies in Community Oncology

What Teplizumab's FDA Approval Means for Pharmacists

Saro's Scripts: Orforglipron

Why NABP's English Proficiency Exam Uses Computer-Based Speaking Tests Over Live Conversations

Saro's Scripts: Insulin Icodec Offers a New Long-Acting Basal Insulin Option

How Pulse by NABP Is Strengthening Pharmaceutical Supply Chain Investigations

New Difamilast Ointment for Atopic Dermatitis

Global Perspectives: Top Takeaways from the Sports Pharmacy Summit

Pharmacists Help Safeguard Athletes From Supplement Risks and Anti-Doping Violations

Understanding Hydrophilic vs. Lipophilic Statins

Why English Proficiency is Essential for US Pharmacists

Is your medicine legitimate? This new tool changes everything

Defining Success for Hem-Onc Pharmacy’s Future

What to Expect at the Sports Pharmacy Summit: Key Topics and Trends

New Atypical Antipsychotic Milsaperidone Explained

Finerenone in HFmrEF and HFpEF: Findings From FINEARTS-HF

Mavacamten in Adolescents with Obstructive HCM

Why Oncology Pharmacist Day Matters: Oncology Pharmacists Share What the Milestone Means to Them

Ryan Tedford Shares Insights About Sotatercept and the CADENCE Trial

Raising Awareness for Women's Cardiovascular Care

2026 Guideline Updates for Dyslipidemia

Clarify When Patients Truly Need Antiseptic Cleansers

Beyond CRS and Neurotoxicity: Underappreciated Adverse Events With Bispecific T-Cell Engagers

Making Evidence-Informed Decisions When irAE Data Falls Short

The Truth About Vaccine Preservatives and Safety